Orchestra BioMed Holdings, Inc. (OBIO)
Last updated: 2026-10-21 20:52:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Orchestra BioMed Holdings, Inc. (OBIO) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $5.81, with a market capitalization of $339.59M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.46 to $6.50. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$339.59M | |
$5.76 | |
$23.39 | |
$2.20 | |
$5.82 | |
254.84K | |
319.45K | |
-- | |
$6.50 | |
$3.46 | |
-- | |
-- |
Orchestra BioMed Holdings, Inc. (OBIO) After-Hours Stock Price
Orchestra BioMed Holdings, Inc. (OBIO) is trading at $5.85 in after-hours trading as of 2026-10-21 20:36:00, up 0.45% ($0.03) from the regular-session close of $5.82.
After-hours trading shows how investors are pricing OBIO after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Orchestra BioMed Holdings, Inc. (OBIO) 7-Day Stock Price Change
Over the past seven days, Orchestra BioMed Holdings, Inc. (OBIO) moved from $5.91 to $5.81, representing a decline of 1.69% ($0.10).
The stock traded between $5.37 and $6.17 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 373.16 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
OBIO 52-Week Price Position
Position in Range: 77.3%
OBIO is currently trading at $5.81, placing it 77.3% of the way from its 52-week low of $3.46 to its 52-week high of $6.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Orchestra BioMed Holdings, Inc. (OBIO)?
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Orchestra BioMed Holdings, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 86 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Orchestra BioMed Holdings, Inc. (OBIO) Stock on MEXC
Eligible investors can buy real shares of Orchestra BioMed Holdings, Inc. (OBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Orchestra BioMed Holdings, Inc. (OBIO) stock price today?
2.Is OBIO stock going up or down today?
3.What is OBIO pre-market price?
4.What is OBIO after-hours price?
5.Is OBIO stock trading now?
6.Where does OBIO sit relative to its 52-week high and low?
7.What sector is Orchestra BioMed Holdings, Inc. in?
8.What is Orchestra BioMed Holdings, Inc.'s market capitalization and where is it listed?
9.How is OBIO valued in terms of P/E ratio and EPS?
10.Does Orchestra BioMed Holdings, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
OBIO Stock Calculator
Estimate the value between OBIO shares and USD.
OBIO Shares to USD
1.00 OBIO shares = 5.81 USD
Calculations are estimates based on the latest available price and are for reference only.


